Antipsychotic polypharmacy in schizophrenia patients in China and its association with treatment satisfaction and quality of life: findings of the third national survey on use of psychotropic medications in China

Q. Li, Y.T. Xiang, Y.A. Su, L. Shu, X. Yu, H.F.K. Chiu, C.U. Correll, Gabor Ungvari, K.Y.C. Lai, C. Ma, G.H. Wang, P.S. Bai, T. Li, L.Z. Sun, J.G. Shi, X.S. Chen, Q.Y. Mei, K.Q. Li, T.M. Si

    Research output: Contribution to journalArticle

    23 Citations (Scopus)

    Abstract

    © The Royal Australian and New Zealand College of Psychiatrists 2014. Objective: This study examined the use, demographic and clinical correlates of antipsychotic polypharmacy (APP) and its associations with treatment satisfaction and quality of life (QOL) in schizophrenia patients in China. Method: A total of 4239 patients in 45 nationwide Chinese psychiatric hospitals/centers were interviewed in 2012 in the third cross-sectional study, with the first two having been conducted in 2002 and 2006. Patients' socio-demographic and clinical characteristics, including psychopathology, side effects, satisfaction with treatment and QOL, were recorded using a standardized protocol and data collection procedure. Results: The proportion of APP prescriptions in 2012 was 34.2%, which was significantly higher than the frequency of APP in 2002 (26.1%) and 2006 (26.4%) (p2=0.31, p
    Original languageEnglish
    Pages (from-to)129-136
    JournalAustralian & New Zealand Journal of Psychiatry
    Volume49
    Issue number2
    DOIs
    Publication statusPublished - 2015

    Fingerprint

    Polypharmacy
    Antipsychotic Agents
    China
    Schizophrenia
    Quality of Life
    Demography
    Psychiatric Hospitals
    Psychopathology
    New Zealand
    Prescriptions
    Psychiatry
    Therapeutics
    Cross-Sectional Studies
    Surveys and Questionnaires

    Cite this

    Li, Q. ; Xiang, Y.T. ; Su, Y.A. ; Shu, L. ; Yu, X. ; Chiu, H.F.K. ; Correll, C.U. ; Ungvari, Gabor ; Lai, K.Y.C. ; Ma, C. ; Wang, G.H. ; Bai, P.S. ; Li, T. ; Sun, L.Z. ; Shi, J.G. ; Chen, X.S. ; Mei, Q.Y. ; Li, K.Q. ; Si, T.M. / Antipsychotic polypharmacy in schizophrenia patients in China and its association with treatment satisfaction and quality of life: findings of the third national survey on use of psychotropic medications in China. In: Australian & New Zealand Journal of Psychiatry. 2015 ; Vol. 49, No. 2. pp. 129-136.
    @article{f8623bd829504309a0a75cb30039fa7e,
    title = "Antipsychotic polypharmacy in schizophrenia patients in China and its association with treatment satisfaction and quality of life: findings of the third national survey on use of psychotropic medications in China",
    abstract = "{\circledC} The Royal Australian and New Zealand College of Psychiatrists 2014. Objective: This study examined the use, demographic and clinical correlates of antipsychotic polypharmacy (APP) and its associations with treatment satisfaction and quality of life (QOL) in schizophrenia patients in China. Method: A total of 4239 patients in 45 nationwide Chinese psychiatric hospitals/centers were interviewed in 2012 in the third cross-sectional study, with the first two having been conducted in 2002 and 2006. Patients' socio-demographic and clinical characteristics, including psychopathology, side effects, satisfaction with treatment and QOL, were recorded using a standardized protocol and data collection procedure. Results: The proportion of APP prescriptions in 2012 was 34.2{\%}, which was significantly higher than the frequency of APP in 2002 (26.1{\%}) and 2006 (26.4{\%}) (p2=0.31, p",
    author = "Q. Li and Y.T. Xiang and Y.A. Su and L. Shu and X. Yu and H.F.K. Chiu and C.U. Correll and Gabor Ungvari and K.Y.C. Lai and C. Ma and G.H. Wang and P.S. Bai and T. Li and L.Z. Sun and J.G. Shi and X.S. Chen and Q.Y. Mei and K.Q. Li and T.M. Si",
    year = "2015",
    doi = "10.1177/0004867414536931",
    language = "English",
    volume = "49",
    pages = "129--136",
    journal = "Australian & New Zealand Journal of Psychiatry",
    issn = "0004-8674",
    publisher = "SAGE Publications Ltd",
    number = "2",

    }

    Antipsychotic polypharmacy in schizophrenia patients in China and its association with treatment satisfaction and quality of life: findings of the third national survey on use of psychotropic medications in China. / Li, Q.; Xiang, Y.T.; Su, Y.A.; Shu, L.; Yu, X.; Chiu, H.F.K.; Correll, C.U.; Ungvari, Gabor; Lai, K.Y.C.; Ma, C.; Wang, G.H.; Bai, P.S.; Li, T.; Sun, L.Z.; Shi, J.G.; Chen, X.S.; Mei, Q.Y.; Li, K.Q.; Si, T.M.

    In: Australian & New Zealand Journal of Psychiatry, Vol. 49, No. 2, 2015, p. 129-136.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Antipsychotic polypharmacy in schizophrenia patients in China and its association with treatment satisfaction and quality of life: findings of the third national survey on use of psychotropic medications in China

    AU - Li, Q.

    AU - Xiang, Y.T.

    AU - Su, Y.A.

    AU - Shu, L.

    AU - Yu, X.

    AU - Chiu, H.F.K.

    AU - Correll, C.U.

    AU - Ungvari, Gabor

    AU - Lai, K.Y.C.

    AU - Ma, C.

    AU - Wang, G.H.

    AU - Bai, P.S.

    AU - Li, T.

    AU - Sun, L.Z.

    AU - Shi, J.G.

    AU - Chen, X.S.

    AU - Mei, Q.Y.

    AU - Li, K.Q.

    AU - Si, T.M.

    PY - 2015

    Y1 - 2015

    N2 - © The Royal Australian and New Zealand College of Psychiatrists 2014. Objective: This study examined the use, demographic and clinical correlates of antipsychotic polypharmacy (APP) and its associations with treatment satisfaction and quality of life (QOL) in schizophrenia patients in China. Method: A total of 4239 patients in 45 nationwide Chinese psychiatric hospitals/centers were interviewed in 2012 in the third cross-sectional study, with the first two having been conducted in 2002 and 2006. Patients' socio-demographic and clinical characteristics, including psychopathology, side effects, satisfaction with treatment and QOL, were recorded using a standardized protocol and data collection procedure. Results: The proportion of APP prescriptions in 2012 was 34.2%, which was significantly higher than the frequency of APP in 2002 (26.1%) and 2006 (26.4%) (p2=0.31, p

    AB - © The Royal Australian and New Zealand College of Psychiatrists 2014. Objective: This study examined the use, demographic and clinical correlates of antipsychotic polypharmacy (APP) and its associations with treatment satisfaction and quality of life (QOL) in schizophrenia patients in China. Method: A total of 4239 patients in 45 nationwide Chinese psychiatric hospitals/centers were interviewed in 2012 in the third cross-sectional study, with the first two having been conducted in 2002 and 2006. Patients' socio-demographic and clinical characteristics, including psychopathology, side effects, satisfaction with treatment and QOL, were recorded using a standardized protocol and data collection procedure. Results: The proportion of APP prescriptions in 2012 was 34.2%, which was significantly higher than the frequency of APP in 2002 (26.1%) and 2006 (26.4%) (p2=0.31, p

    U2 - 10.1177/0004867414536931

    DO - 10.1177/0004867414536931

    M3 - Article

    VL - 49

    SP - 129

    EP - 136

    JO - Australian & New Zealand Journal of Psychiatry

    JF - Australian & New Zealand Journal of Psychiatry

    SN - 0004-8674

    IS - 2

    ER -